The Assistant Controller of Patents and Designs on 7 November 2016 allowed two applications of Pfizer Ireland covering their commercial method for production of Etanercept, dismissing four pre-grant oppositions.
Packaging, labelling and marketing of pharmaceuticals has evolved rapidly in India, with concerns about ‘deceptive similarity’ at the helm. Our Pharma Dossier (Vol. 1) discusses trade mark jurisprudence
In proceedings initiated by US pharmaceutical major Pfizer Inc. for infringement of its patent against a Hyderabad based generic drug manufacturer, the Delhi High Court has restrained the defendants
Lysosomal Storage Disorders (LSDs) are rare hereditary disorders which usually afflict children, proving fatal within a few years of birth. The necessary treatment, Enzyme Replacement Therapy, is prohibitively
An analysis of the decision in Merck Sharp & Dohme Corp. & Anr. Vs. Glenmark Pharmaceuticals Ltd. – the first patent infringement contested lawsuit under the Patents Act
The Supreme Court’s affirmation of the High Court injunction related to the infringement of Merck’s Indian patent for sitagliptin, an oral hyperglycemic drug brings a unique perspective on
Parties can apply for a compulsory licence in India on several grounds, including that the invention is not worked in the country. Neeti Wilson explores. 2015 marks a
Since 2011 – for a period of more than two years – the weakest intellectual property legislation in relation to the world of chemistry, i.e. patent law in
In a breakthrough decision with significant implications for patent prosecution in India, an Indian court has read “wilfulness” into Section 8 of India’s Patents Act. A Delhi High
